Test Price
2,800 AED✅ Home Collection Available
IL12A Gene (Interleukin 12A Deficiency) Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
Executive Summary – Premium Diagnostic Service with Home Collection
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily 8 AM–11 PM.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by DHA-licensed Genetic Counsellor.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This next-generation sequencing (NGS) test comprehensively analyses the IL12A gene to identify pathogenic variants responsible for interleukin 12A deficiency—a rare, primary immunodeficiency that predisposes to severe mycobacterial and fungal infections. Full gene sequencing with copy number variation (CNV) analysis ensures high diagnostic yield.
| Feature | Our Test (DHA Licensed) | Closest Alternative |
|---|---|---|
| Precision / Coverage | Full gene sequencing with CNV analysis | Targeted mutation panels (limited loci) |
| Methodology | NGS (Illumina, 2x150 bp) | Sanger sequencing (single exon) |
| Turnaround Time | 3–4 Weeks | 4–6 Weeks |
| Variant Classification | ACMG/AMP guidelines, ClinVar integration | Limited or no clinical annotation |
| Post‑test Genetic Counselling | Included (telephonic) | Often not included |
Physician Insight & Safety Protocols
“Genetic testing for IL12A deficiency requires careful interpretation within the full clinical context. A positive result confirms susceptibility, but absence of a known mutation does not exclude disease—a comprehensive immunological assessment remains essential. Patient safety depends on coordinated care among immunology, genetics, and infectious disease teams.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Medication Advisory
Important Safety Notice
Do not discontinue prescribed medication without consulting your doctor. Genetic test information must not be used to alter immunosuppressive or antimicrobial therapy without specialist guidance.
Exclusion Criteria & Emergency Red Flags
- Patients with active, uncontrolled bleeding disorders (contraindication for phlebotomy).
- Inability to provide informed consent or genetic counselling consent as per Federal Decree-Law No. 4 of 2016 on Medical Liability.
- For minors: joint consent from guardian and treating paediatrician as per Federal Law No. 2 of 2019 concerning Use of ICT in Health Fields.
- Emergency Red Flags: If you develop high fever, new skin ulcers, or signs of severe infection before or after testing, seek immediate medical attention at the nearest DHA‑licensed emergency department.
Patient FAQ & Clinical Guidance
1. What is the IL12A genetic test and why is it needed?
The IL12A genetic test identifies DNA mutations causing interleukin-12 deficiency, a primary immunodeficiency with severe infection risk. It is recommended for patients with recurrent atypical mycobacterial infections, disseminated BCGitis after vaccination, or chronic mucocutaneous fungal infections where primary immune deficiency is suspected.
2. How is the test performed and what sample is required?
A small blood sample, extracted DNA, or a single drop of blood on an FTA card is collected by a DHA‑certified phlebotomist through our cold‑chain home collection service, ensuring sample stability and compliance with ISO 9001:2015 logistics protocols. VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection is available daily from 8 AM to 11 PM.
3. When will I receive my results and how are they interpreted?
Results are available in 3 to 4 weeks and include a detailed clinical report with ACMG classification; a post‑test telephonic genetic counselling session is automatically scheduled to explain your variant’s significance and next steps.
4. Does insurance cover the IL12A genetic test?
We provide direct billing verification with major insurance providers. Please contact our billing team via WhatsApp at +971 54 548 8731 for pre-approval and coverage details.
UAE Regulatory & Data Privacy Adherence
Your data is protected under UAE law. This test is performed in compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is handled with strict confidentiality, stored securely, and never shared without explicit patient consent. Clinical safety and consent procedures follow Federal Decree-Law No. 4 of 2016 on Medical Liability.
Clinical & Logistical Metadata
| Test Name | IL12A Gene (Interleukin 12A Deficiency) Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 21–28 Business Days (3–4 Weeks) |
| Sample Type / Matrix | Peripheral Whole Blood (3–5 mL EDTA) or Extracted DNA |
| Methodology Used | Next-Generation Sequencing (NGS) – Illumina, 2x150 bp, with CNV analysis |
| ICD-10-CM Code | D84.8 (Other specified immunodeficiencies) |
| LOINC Code | 55233-1 (Genetic analysis) |
| DHA Facility License & Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians